Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 7691344)

Published in Hum Mol Genet on August 01, 1993

Authors

M Claustres1, M Laussel, M Desgeorges, M Giansily, J F Culard, G Razakatsara, J Demaille

Author Affiliations

1: Laboratoire de Biochimie Génétique, CNRS UPR-9008, Montpellier, France.

Articles citing this

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68

A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet (1995) 1.29

Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med Genet (2004) 0.99

Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet (1995) 0.97

Mutation analysis in 600 French cystic fibrosis patients. J Med Genet (1994) 0.97

Functional analysis of synonymous substitutions predicted to affect splicing of the CFTR gene. J Cyst Fibros (2012) 0.85

Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy. BMC Med Genet (2004) 0.85

Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis. J Med Genet (1997) 0.84

Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Am J Hum Genet (2000) 0.83

Crucial role for phylogenetically conserved cytoplasmic loop 3 in ABCC4 protein expression. J Biol Chem (2013) 0.80

The use of DHPLC (Denaturing High Performance Liquid Chromatography) in II level screening of the CFTR gene in Prenatal Diagnosis. J Prenat Med (2010) 0.75

Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California. PLoS One (2016) 0.75

Severe pulmonary and digestive disease in a cystic fibrosis child homozygous for G542X. J Med Genet (1994) 0.75

Articles by these authors

Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. Genomics (2000) 1.88

Distribution of olfactory receptor genes in the human genome. Nat Genet (1998) 1.78

Comparative genomics of the SOX9 region in human and Fugu rubripes: conservation of short regulatory sequence elements within large intergenic regions. Genomics (2001) 1.72

From first base: the sequence of the tip of the X chromosome of Drosophila melanogaster, a comparison of two sequencing strategies. Genome Res (2001) 1.64

Heterotaxia syndrome and autosomal dominant inheritance. Am J Med Genet (1995) 1.55

Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet (1998) 1.55

Absence of dystrophin and utrophin in a boy with severe muscular dystrophy. N Engl J Med (1994) 1.39

A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer (1975) 1.24

MEFV mutations in Behçet's disease. Hum Mutat (2000) 1.13

Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet (1998) 1.13

Segregation of a mutation in CNGB1 encoding the beta-subunit of the rod cGMP-gated channel in a family with autosomal recessive retinitis pigmentosa. Hum Genet (2001) 1.11

Muscular parvalbumins: preparative and analytical methods of general applicability. Biochim Biophys Acta (1971) 1.10

BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies. Invest Ophthalmol Vis Sci (2000) 1.10

Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD. J Med Genet (1998) 1.09

First report of CFTR mutations in black cystic fibrosis patients of southern African origin. J Med Genet (1996) 1.06

Evolution of the Gypsy endogenous retrovirus in the Drosophila melanogaster subgroup. Mol Biol Evol (2000) 1.06

Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat (1999) 1.03

The first green lineage cdc25 dual-specificity phosphatase. Cell Cycle (2004) 1.00

An isolated cardiac conduction disease maps to chromosome 19q. Circ Res (1995) 0.98

High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens. N Engl J Med (1993) 0.96

The variable surface glycoproteins of Trypanosoma equiperdum are phosphorylated. EMBO J (1982) 0.95

Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens. Hum Genet (1994) 0.95

A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression. J Biol Chem (2000) 0.95

Reconstituted skin in culture: a simple method with optimal differentiation. Differentiation (1990) 0.95

The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum (2001) 0.94

Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun (2002) 0.94

The molecular basis of cystic fibrosis in South Africa. Clin Genet (2001) 0.94

Novel missense mutation in the first transmembrane segment of the CFTR gene (Q98R) identified in a male adult. Hum Mutat (1995) 0.93

Spatial and temporal expression of the cystathionine beta-synthase gene during early human development. Biochem Biophys Res Commun (1999) 0.92

Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity. Eur J Hum Genet (2000) 0.91

Germinal mosaicism from grand-paternal origin in a family with Duchenne muscular dystrophy. Hum Genet (1990) 0.90

[Isolation, physico-chemical properties and composition of pig alpha 2-macroglobulin]. Bull Soc Chim Fr (1965) 0.89

Troponins C from reptile and fish muscles and their relation to muscular parvalbumins. FEBS Lett (1974) 0.89

The primary structure of the major parvalbumin from hake muscle. Overlapping peptides obtained with chemical and enzymatic methods. The complete amino-acid sequence. Eur J Biochem (1973) 0.89

The distribution of parvalbumins in muscle and in other tissues. FEBS Lett (1975) 0.89

Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum Genet (1997) 0.87

Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: from Southern blot to protein truncation test. Hum Genet (1998) 0.87

Mode of stimulation by injection of cyclic AMP and external acidification of the sodium efflux in barnacle muscle fibres. J Physiol (1979) 0.87

Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone. Hum Genet (1999) 0.85

[Aneurysms of the pericallosal artery. Apropos of a series of 12 cases]. Neurochirurgie (1973) 0.85

First putative sequence alterations in the minimal CFTR promoter region. J Med Genet (1999) 0.85

Expression and subcellular localization of dystrophin in skeletal, cardiac and smooth muscles during the human development. Neuromuscul Disord (1995) 0.85

Implications for cAMP-dependent protein kinase in the maintenance of the interphase state. Prog Cell Cycle Res (1995) 0.84

Splice mutation 1811+1.6kbA>G causes severe cystic fibrosis with pancreatic insufficiency: report of 11 compound heterozygous and two homozygous patients. J Med Genet (2002) 0.83

[Atlanto-axial lateral mass osteoarthritis. Three case reports and review of the literature]. Neurochirurgie (2001) 0.83

Stereotactic biopsy of the brain with the Leksell frame in the context of modern radiology. J Neuroradiol (1988) 0.83

Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A (2003) 0.83

Towards structural models of molecular recognition in olfactory receptors. Biochimie (1998) 0.83

First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol Hum Reprod (2003) 0.83

[Intracranial schwannomas of the cranial nerves. The acoustic nerve excluded]. Acta Otorhinolaryngol Belg (1987) 0.82

Haplotype analysis of the HFE gene: implications for the origins of hemochromatosis related mutations. Blood Cells Mol Dis (1999) 0.82

Evolution of Ca2+- and cAMP-dependent regulatory mechanisms during ram spermatogenesis. Dev Biol (1983) 0.81

Molecular analysis of the rhodopsin gene in southern France: identification of the first duplication responsible for retinitis pigmentosa, c.998999ins4. Ophthalmic Genet (1999) 0.81

[Anesthesia in surgery of acoustic neuroma by the trans-petrous approach]. Ann Otolaryngol Chir Cervicofac (1986) 0.81

Multiplex fluorescent RT-PCR to quantify leukemic fusion transcripts. Biotechniques (2002) 0.81

Evaluation of dHPLC for CX26 mutation screening in patients from southern France with sensorineural deafness. Genet Test (2001) 0.81

[Intraventricular cerebral tuberculoma. Apropos of a case]. Ann Med Interne (Paris) (1977) 0.81

Multimodal anatomic, functional, and metabolic brain imaging for tumor resection. Clin Imaging (2002) 0.80

Deciphering the molecular genetics of congenital heart disease. Herz (1994) 0.80

[A new inhibitor, fuscin, in the study of animal and yeast mitochondria respiratory chains]. Eur J Biochem (1970) 0.80

[Clinical application of functional MRI: a strategic tool for neurosurgery]. J Neuroradiol (2000) 0.80

CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern France. Hum Genet (1996) 0.80

Identification of a 6 bp deletion (3195del6) in exon 17a of the cystic fibrosis (CFTR) gene. Hum Mol Genet (1994) 0.79

Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test. Hum Genet (1996) 0.79

Protein truncation test: analysis of two novel point mutations at the carboxy-terminus of the human dystrophin gene associated with mental retardation. Hum Mutat (1995) 0.79

[CFTR gene analyis in 207 patients with cystic fibrosis in southwest France: high frequency of N1303K and 1811+1.6bA>G mutations]. Arch Pediatr (2001) 0.79

Genotypic diagnosis of familial Mediterranean fever (FMF) using new microsatellite markers: example of two extensive non-Ashkenazi Jewish pedigrees. J Med Genet (1997) 0.79

[Subdural hematoma and anticoagulant therapy]. Neurochirurgie (1976) 0.79

[Diagnosis of minor chromosome modifications by molecular cytogenetics]. Ann Genet (1989) 0.78

[Postoperative quality of life for patients with a vestibular schwannoma]. Ann Otolaryngol Chir Cervicofac (2004) 0.78

[Neuronavigation in third ventricle tumors]. Neurochirurgie (2000) 0.78

Four novel dystrophin point mutations: detection by protein truncation test and transcript analysis in lymphocytes from Duchenne muscular dystrophy patients. Eur J Hum Genet (1996) 0.78

Homozygosity for a novel missense mutation (I175V) in exon 5 of the CFTR gene in a family of Armenian descent. Hum Mol Genet (1994) 0.78

A novel mutation (S558X) causing choroideremia. Hum Mutat (1996) 0.78

Recurrent PIG-A mutation (IVS5+1G-->A) in a paediatric case of paroxysmal nocturnal haemoglobinuria: detection by the protein truncation test. Br J Haematol (1997) 0.78

Specific detection of deleted and non-deleted dystrophin exons together with gender assignment in preimplantation genetic diagnosis of Duchenne muscular dystrophy. Mol Hum Reprod (2003) 0.77

The amino-acid sequence of the most acidic major parvalbumin from frog muscle. Eur J Biochem (1975) 0.77

Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining. Neuromuscul Disord (1992) 0.77

Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. J Rheumatol (1998) 0.77

[Arachnoid cysts of the middle fossa and associated subdural hematoma. Three case reports and review of the literature]. Neurochirurgie (2000) 0.76

A novel mutation (Val-373 to Glu) in the catalytic domain of factor IX, resulting in moderately/severe hemophilia B in a southern French patient. Hum Mutat (1994) 0.76

Lattice corneal dystrophy. Ophthalmology (2000) 0.76

The myosin light chain kinase gene is not duplicated in mouse: partial structure and chromosomal localization of Mylk. Genomics (2001) 0.76

Protein truncation test: detection of severe haemophilia a mutation and analysis of factor VIII transcripts. Hum Mutat (1998) 0.76

A complex allele (1064delTC and IVS2 + 22ins7) in the peripherin/RDS gene in retinitis pigmentosa with macular dystrophy. Ophthalmic Genet (1997) 0.76

Surgical treatment of large vestibular schwannomas (stages III and IV). Eur Ann Otorhinolaryngol Head Neck Dis (2010) 0.76

A novel splice site mutation in the first exon of the cystic fibrosis transmembrane regulator (CFTR) gene identified in a CBAVD patient. Hum Mol Genet (1994) 0.76

The protein truncation test (PTT) as a method of detection for choroideremia mutations. Exp Eye Res (1997) 0.76

W179R: a novel missense mutation in the peripherin/RDS gene in a family with autosomal dominant retinitis pigmentosa. Hum Mutat (2000) 0.76